Kolon Life Science Inc (102940) — Cash Flow Reinvestment Rate
Kolon Life Science Inc (102940) has a Cash Flow Reinvestment Rate of 4.34x as of September 2025, reinvesting ₩11.20 Billion (capex ₩8.05 Billion plus investments ₩-3.15 Billion) from operating cash flow of ₩2.58 Billion. See 102940 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kolon Life Science Inc Cash Flow Reinvestment Rate (2011–2016)
Historical reinvestment intensity for Kolon Life Science Inc across 5 annual periods. For the full cash flow conversion analysis, see Kolon Life Science Inc cash conversion from operations.
Annual Cash Flow Reinvestment Rate for Kolon Life Science Inc (2011–2016)
Year-by-year capital reinvestment analysis for Kolon Life Science Inc. See financial agility of Kolon Life Science Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2016 | 1.46x | ₩41.03 Billion | ₩28.11 Billion | ₩16.14 Billion | ▼ -24.3% |
| 2015 | 1.93x | ₩40.11 Billion | ₩20.81 Billion | ₩15.22 Billion | ▼ -7.7% |
| 2014 | 2.09x | ₩25.26 Billion | ₩12.10 Billion | ₩15.01 Billion | ▼ -24.9% |
| 2012 | 2.78x | ₩64.96 Billion | ₩23.37 Billion | ₩61.01 Billion | ▲ +2.9% |
| 2011 | 2.70x | ₩31.47 Billion | ₩11.65 Billion | ₩27.52 Billion | — |